Covid-19

MedNews is a FREE SERVICE of Medical and Pharma Insider in conjunction with BCI News Service.

To have your company news featured at Medical and Pharma Insider, please visit www.bcinewsservice.com.

View our disclaimer/disclosure

Featuring MedNews and MedTalks Videos, video conversations with management of medical, pharma, biopharma, healthcare, telemedicine, and medical device companies.

Nov 15, 2022
2 min

iXensor, with its technology that turns smartphones into self-testing devices, partners with Innova

Expedited by the COVID-19 pandemic, some medical testing has shifted from central labs to point-of-care and now to consumers’ homes.

Oct 24, 2022
4 min

Biotechs, Developing Countries, Vaccine Manufacturers and Pharma Unite for Better Vaccine Access

The proposal offers to reserve a real-time allocation of vaccines production for vulnerable populations in lower-income countries.

Jun 7, 2022
2 min

OriCiro Closes on Financing to Advance Cell-Free Cloning technology for Large Circular DNA

OriCiro Genomics’ unique cell-free DNA technology has a tremendous potential for business applications, particularly for healthcare.

May 7, 2022
2 min

Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories

Apr 15, 2022
4 min

With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test

“The PictArray™ SARS-CoV-2 Antibody Test is a high performance, all-in-one, NP/SP COVID-19 antibody test with serological differentiation.

Apr 6, 2022
3 min

Contract development and manufacturing organization BioCina receives a grant to advance RNA vaccines

BioCina has pharmaceutical development and manufacturing experience, augmented with the acquisition of Pfizer’s facilities in Australia

Mar 24, 2022
3 min

Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic

Sen-Jam and KVK Tech will complete their phase II clinical trials or their oral COVID-19 drug, to have a finished product in 9-12 months.

Feb 23, 2022
2 min

COVID forces Marinus Pharmaceuticals to delay Phase 3 trials for seizure disorder therapeutic

The trial delays are due to COVID-19 Omicron variant on hospital resources and an unexpected interruption of clinical supply material.

Dec 28, 2021
3 min

Rockefeller Foundation funds Helix to advance data and technology for COVID surveillance & variants

Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics.

Nov 28, 2021
2 min

Enzychem and Zydus Cadila partner to manufacture COVID plasmid DNA vaccine in Korea

yCoV-D® was recently granted emergency use approval (EUA) by India’s national regulatory agency for subjects 12 years and above.

Nov 17, 2021
2 min

Amcyte Pharma launches nasal spray to reduce COVID transmission

We are excited to be commercializing Nasitrol nasal spray, a product that has shown such promise as a prophylaxis against COVID transmission

Oct 26, 2021
2 min

Air Products (NYSE: APD) and Sublime Stericeuticals to develop freeze-drying equipment for vaccines

Freeze-drying, or lyophilization, is regularly used to preserve biological products such as vaccines and antihemophilic proteins.

Oct 6, 2021
4 min

NanoViricides (NYSE: NNVC) provides update of its Pan-Coronavirus COVID-19 drug development program

"Oral NV-CoV-2 should enable highly effective treatments for pediatric use, an urgent medical need that remains unmet..."

Aug 26, 2021
3 min

NRx Pharmaceuticals closes on $30 million to advance its drug for the sickest of COVID-19 patients

NRx Pharmaceuticals has more than 300 years of collective, scientific and drug-development experience to bring improved health to patients.

Jul 13, 2021
4 min

NrX Pharmaceuticals and the Israel Institute for Biological Research join for Coronavirus vaccine

The BriLife™ vaccine (technical name VSV ΔG1) is based on a previous, FDA-approved vaccine platform...and targeted towards COVID-19...

Jun 23, 2021
2 min

SaNOtize begins enrollment for Phase III trials for its COVID-19 anti-viral treatment

The SaNOtize treatment is based on nitric oxide a natural nanomolecule produced by the human body with proven anti-microbial properties

May 25, 2021
6 min

NeuroRx merges with Big Rock Partners and begins trading on Nasdaq under the stock symbol NRXP

NRx expects to seek Emergency Use Authorization from the FDA to treat critical Covid-19 in patients suffering respiratory failure.

Apr 29, 2021
3 min

Scone Medical Solutions receives US patent for negative pressure environment

The SCONE is a barrier protection device that uses negative pressure technology to remove potentially harmful airborne particulates...

Apr 26, 2021
2 min

Kintor Pharmaceutical starts US Phase III trials for the treatment of Covid-19 symptoms

Initiation of this phase III study of proxalutamide for COVID-19 symptoms is a key milestone in the development of therapies

Apr 15, 2021
3 min

Kintor Pharmaceutical and Hainan Visum Pharmaceutical announce strategic partnership

Preliminary data indicates that after treatment, the risk of hospitalization for patients with mild or moderate COVID-19 is reduced 90%+